Biofarm S.A. (BVB:BIO)

Market Cap	1.28B +86.1%
Revenue (ttm)	319.33M +11.4%
Net Income	100.82M +35.5%
EPS	n/a
Shares Out	985.37M
PE Ratio	12.66
Forward PE	n/a
Dividend	0.03 (2.39%)
Ex-Dividend Date	Aug 18, 2025

Volume	83,288
Average Volume	180,718
Open	1.305
Previous Close	1.300
Day's Range	1.280 - 1.310
52-Week Range	0.620 - 1.355
Beta	0.51
RSI	63.35
Earnings Date	Feb 27, 2026

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 367
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2025, Biofarm's revenue was 330.43 million, an increase of 15.23% compared to the previous year's 286.77 million. Earnings were 100.82 million, an increase of 35.51%.